Abstract

? CANCER PREVENTION AND CONTROL (CPC) PROGRAM The Cancer Prevention and Control (CPC) Program of The Tisch Cancer Institute (TCI) is comprised of 38 members who share a common goal to reduce the burden of cancer incidence and mortality and improve the lives of cancer patients, with emphasis on the population in the impact catchment area of TCI. Collaboratively, they study cancer risk factors, early detection and screening and healthcare delivery. They represent 20 Departments and 11 Institutes. As of February 2019, CPC program members were awarded $6.7 million in direct cost funding, with NCI support of $2.1 million and peer-reviewed cancer related support of $5.4 million. In 2018, the program published 119 papers of which 34% were intra- and 10% were inter- programmatic. CPC members conduct collaborative research that addresses the three themes of the program: 1) Risk Factor Evaluation and Mitigation, 2) Cancer Early Detection and Screening, and 3) Healthcare Delivery.
The aims of the program are to evaluate and mitigate cancer risk factors with special attention to those most prevalent in the catchment area, to develop effective early detection and screening strategies for groups at higher risk while addressing health disparities, and to improve the quality of care and quality of life of people affected by cancer through healthcare delivery.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA196521-06
Application #
10022664
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
2015-08-01
Project End
2025-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost

  Institution

Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029

  Publications

Labgaa, Ismail; Villacorta-Martin, Carlos; D'Avola, Delia et al. (2018) A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma. Oncogene 37:3740-3752
Mascarenhas, J; Virtgaym, E; Stal, M et al. (2018) Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study. Ann Hematol 97:1369-1374
Wu, Lisa M; Amidi, Ali; Valdimarsdottir, Heiddis et al. (2018) The Effect of Systematic Light Exposure on Sleep in a Mixed Group of Fatigued Cancer Survivors. J Clin Sleep Med 14:31-39
Miller, Albert; Szeinuk, Jaime; Noonan, Curtis W et al. (2018) Libby Amphibole Disease: Pulmonary Function and CT Abnormalities in Vermiculite Miners. J Occup Environ Med 60:167-173
Vuong, Linh T; Iomini, Carlo; Balmer, Sophie et al. (2018) Kinesin-2 and IFT-A act as a complex promoting nuclear localization of ?-catenin during Wnt signalling. Nat Commun 9:5304
Bickell, Nina A; Lin, Jenny J; Abramson, Sarah R et al. (2018) Racial Disparities in Clinically Significant Prostate Cancer Treatment: The Potential Health Information Technology Offers. J Oncol Pract 14:e23-e33
Li, Weiqiang; Middha, Mridu; Bicak, Mesude et al. (2018) Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival. Eur Urol 74:710-719
Nobre, Ana Rita; Entenberg, David; Wang, Yarong et al. (2018) The Different Routes to Metastasis via Hypoxia-Regulated Programs. Trends Cell Biol 28:941-956
Zhang, Maomao; Di Martino, Julie S; Bowman, Robert L et al. (2018) Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins. Cancer Discov 8:1006-1025
Leiter, Amanda; Bickell, Nina A; LeRoith, Derek et al. (2018) Statin Use and Breast Cancer Prognosis in Black and White Women. Horm Cancer 9:55-61

Showing the most recent 10 out of 143 publications